Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024

BUY
$4.86 - $6.39 $53,460 - $70,290
11,000 New
11,000 $55,000
Q2 2023

Aug 11, 2023

SELL
$8.94 - $11.74 $199,362 - $261,802
-22,300 Reduced 42.23%
30,500 $310,000
Q1 2023

May 16, 2023

BUY
$5.59 - $9.47 $3,913 - $6,629
700 Added 1.34%
52,800 $478,000
Q4 2022

Feb 14, 2023

BUY
$4.02 - $7.53 $209,441 - $392,313
52,100 New
52,100 $373,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $92.9M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.